본문으로 건너뛰기

Deng T ⚠ 동명이인 가능성

제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column

이름 + 이니셜 1자만으로는 동명이인 구분이 어렵습니다. 상세 비교는 Deng T 비교 뷰 →

39 논문
38 최근 5년
32 최근 1년
2018–2026 활동기

주요 저널

  • BMC cancer 2
  • Investigational new drugs 1
  • Nutrients 1
  • The Journal of clinical endocrinology and metabolism 1
  • Cancer communications (London, England) 1
  • European journal of medicinal chemistry 1

주요 카테고리

주요 공저자 Top 10

  1. Yang Y 7편
  2. Li H 7편
  3. Ba Y 6편
  4. Zhang L 6편
  5. Wang Z 6편
  6. Liu R 5편
  7. Li X 5편
  8. Wang Y 5편
  9. Zhang Y 5편
  10. Liu Y 4편

연도별 분포

  • 2026 14
  • 2025 18
  • 2024 4
  • 2023 1
  • 2022 1
  • 2018 1

최근 발표

공저자 네트워크

중심 = Deng T · 공저 횟수 상위 30
공저자 엣지
본인 공저자 본인-공저자 공저자 사이
⏳ 그래프 로딩 중…

노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁

논문 목록

4건
  • Targeting Acod1/itaconate in cancer therapy: Mechanisms and opportunities.
    Pharmacological research 2026 Deng T (제1저자) PMID: 41692038

    Globally, cancer claims nearly 10 million lives annually, where tumor heterogeneity, the immunosuppressive microenvironment, and therapeutic resistance constitute fundamental clinical challenges. In recent years, immunometabolic reprogrammi…

  • Global trends in thyroid cancer 1990-2021: an analysis based on the GBD 2021.
    Endocrine-related cancer 2025 Deng T (제1저자) PMID: 39878570

    This study evaluated the global burden of thyroid cancer (TC) from 1990 to 2021, analyzing its association with sociodemographic factors, sex, age, risk factors and future projections. Using 2021 global burden of disease data, we analyzed T…

  • Cathepsins and cancer risk: a Mendelian randomization study.
    Frontiers in endocrinology 2024 Deng T (제1저자) PMID: 38883596

    [BACKGROUND] Previous observational epidemiological studies reported an association between cathepsins and cancer, however, a causal relationship is uncertain. This study evaluated the causal relationship between cathepsins and cancer using…

  • Rapidly-manufactured CD276 CAR-T cells exhibit enhanced persistence and efficacy in pancreatic cancer.
    Journal of translational medicine 2024 Deng T (제1저자) PMID: 38978106

    [BACKGROUND] Pancreatic cancer is one of the most lethal malignancies and the lack of treatment options makes it more deadly. Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy has revolutionized cancer treatment and made great breakthr…